FIELD: pharmaceutics.
SUBSTANCE: present invention relates to a method for producing a mixture containing a trans-isomeric compound of the Formula (I) given below or its pharmaceutically acceptable salt:
(I).
The method includes hydrogenation of a compound of the Formula (II) given below or its pharmaceutically acceptable salt:
(II),
in the presence of a palladium catalyst in an inert solvent medium to obtain a mixture containing the trans-isomeric compound of the formula (I) having a ratio of trans:cys forms of at least 70:30 or its pharmaceutically acceptable salt, where R1 in Formulas (I) and (II) is methyl, and where the inert solvent is H2O, C1-C10 complex ester, C1-C10 alcohol or organic acid, or a combination thereof.
EFFECT: invention allows for obtaining trans-isomeric piperidines with high yield and high stereoselectivity.
14 cl, 1 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIVIRAL COMPOUNDS | 2009 |
|
RU2505540C2 |
ANTIVIRAL COMPOUNDS | 2009 |
|
RU2505539C2 |
ISOQUINOLINE DERIVATIVES AS Rho-KINASE INHIBITORS | 2006 |
|
RU2443688C2 |
COMPOUNDS WITH SULFAMOYL AND AMIDINE GROUP, PROCESS FOR PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPOUNDS | 1994 |
|
RU2126382C1 |
PIPERIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITION SHOWING ACTIVITY AS ANTAGONIST OF OPIOID PERIPHERAL ACTION | 1992 |
|
RU2076863C1 |
N1-(4-(5-(CYCLOPROPYLMETHYL)-1-METHYL-1H-PYRAZOLE-4-YL)PYRIDINE-2-YL)CYCLOHEXANE-1,4-DIAMINE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF CK1 AND/OR IRAK1 FOR THE TREATMENT OF CANCER | 2018 |
|
RU2761457C2 |
ACIDIFIED ARYLCYCLOALKYLAMINS AND THEIR APPLICATION AS PHARMACEUTICAL DRUGS | 2003 |
|
RU2337094C2 |
[(BENZODIOXANE, BENZOFURAN OR BENZOPYRANE)-ALKYLAMINO]-ALKYL- -SUBSTITUTED GUANIDINES AS SELECTIVE VASOCONSTRICTORS, METHODS OF THEIR SYNTHESIS, INTERMEDIATES FOR THEIR, PHARMACEUTICAL COMPOSITION AND A METHOD OF ITS PREPARING | 1993 |
|
RU2121999C1 |
PYRAZOLOPYRIDINE DERIVATIVES AS KINASE 1β-ADRENERGIC RECEPTOR INHIBITORS | 2006 |
|
RU2415855C2 |
CYCLOHEXYLAMINIZOQUINOLONE AS Rho-KINASE INHIBITORS | 2006 |
|
RU2440988C2 |
Authors
Dates
2021-11-12—Published
2018-08-10—Filed